TABLE 3.
Top 5 most frequently prescribed antimicrobial drugs in animals with urinary tract infections, respiratory tract infections, and skin infections in dogs and cats
| Dog urinary tract | n | % of prescriptions | % of visits | Cat urinary tract | n | % of prescriptions | % of visits |
| Aminopenicillin/β‐lactamase inhibitor | 842 | 30.9% | 15.8% | Aminopenicillin/β‐lactamase inhibitor | 268 | 43.5% | 11.4% |
| Fluoroquinolone | 448 | 16.4% | 8.4% | Fluoroquinolone | 90 | 14.6% | 3.8% |
| Cephalosporin (first generation) | 377 | 13.8% | 7.1% | Cephalosporin (third generation) | 65 | 10.6% | 2.8% |
| Aminopenicillin | 256 | 9.4% | 4.8% | Aminopenicillin | 54 | 8.8% | 2.3% |
| Nitroimidazole | 192 | 7.0% | 3.6% | Cephalosporin (first generation) | 48 | 7.8% | 2.0% |
| Dog respiratory | n | % of prescriptions | % of visits | Cat respiratory | n | % of prescriptions | % of visits |
| Aminopenicillin/β‐lactamase inhibitor | 832 | 30.5% | 16.2% | Aminopenicillin/β‐lactamase inhibitor | 203 | 43.1% | 15.5% |
| Fluoroquinolone | 589 | 21.6% | 11.5% | Tetracycline | 64 | 13.6% | 4.9% |
| Tetracycline | 421 | 15.4% | 8.2% | Macrolide | 60 | 12.7% | 4.6% |
| Cephalosporin (first generation) | 251 | 9.2% | 4.9% | Fluoroquinolone | 53 | 11.3% | 4.0% |
| Lincosamide | 240 | 8.8% | 4.7% | Cephalosporin (third generation) | 31 | 6.6% | 2.4% |
| Dog skin | n | % of prescriptions | % of visits | Cat skin | n | % of prescriptions | % of visits |
| Cephalosporin (first generation) | 1507 | 34.8% | 11.7% | Cephalosporin (third generation) | 247 | 36.1% | 12.6% |
| Cephalosporin (third generation) | 857 | 19.8% | 6.6% | Aminopenicillin/β‐lactamase inhibitor | 224 | 32.7% | 11.4% |
| Aminopenicillin/β‐lactamase inhibitor | 752 | 17.4% | 5.8% | Fluoroquinolone | 53 | 7.7% | 2.7% |
| Fluoroquinolone | 313 | 7.2% | 2.4% | Cephalosporin (first generation) | 48 | 7.0% | 2.5% |
| Lincosamide | 242 | 5.6% | 1.9% | Lincosamide | 28 | 4.1% | 1.4% |